Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34810
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aktaş, Nimet | - |
dc.date.accessioned | 2023-11-09T06:21:49Z | - |
dc.date.available | 2023-11-09T06:21:49Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Oruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450. | en_US |
dc.identifier.issn | 0211-6995 | - |
dc.identifier.issn | 1989-2284 | - |
dc.identifier.uri | https://doi.org/10.1016/j.nefroe.2018.04.004 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S2013251418300622 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34810 | - |
dc.language.iso | en | en_US |
dc.publisher | Soc Espanola Nefrologia Dr Rafael Matesanz | fre |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Urology & nephrology | en_US |
dc.subject | Complement inhibitor eculizumab | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antibodies, monoclonal, humanized | en_US |
dc.subject.mesh | Atypical hemolytic uremic syndrome | en_US |
dc.subject.mesh | Chemical and drug induced liver injury | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.title | Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome | en_US |
dc.title.alternative | Hepatotoxicidad asociada con eculizumab en un paciente con síndrome urémico hemolítico atípico | fre |
dc.type | Letter | en_US |
dc.identifier.wos | 000439099700019 | tr_TR |
dc.identifier.scopus | 2-s2.0-85049994526 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/ İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-0342-9692 | tr_TR |
dc.contributor.orcid | 0000-0003-4607-9220 | tr_TR |
dc.identifier.startpage | 448 | tr_TR |
dc.identifier.endpage | 450 | tr_TR |
dc.identifier.volume | 38 | tr_TR |
dc.identifier.issue | 4 | tr_TR |
dc.relation.journal | Nefrologia | en_US |
dc.contributor.buuauthor | Oruç, Ayşegül | - |
dc.contributor.buuauthor | Ayar, Yavuz | - |
dc.contributor.buuauthor | Vuruşkan, Berna Aytaç | - |
dc.contributor.buuauthor | Yıldız, Abdülmecit | - |
dc.contributor.buuauthor | Yavuz, Mahmut | - |
dc.contributor.buuauthor | Güllülü, Mustafa | - |
dc.contributor.buuauthor | Dilek, Kamil | - |
dc.contributor.buuauthor | Ersoy, Alparslan | - |
dc.contributor.researcherid | AAH-4002-2021 | tr_TR |
dc.contributor.researcherid | O-9948-2015 | tr_TR |
dc.contributor.researcherid | AAH-9746-2021 | tr_TR |
dc.contributor.researcherid | AGF-0767-2022 | tr_TR |
dc.contributor.researcherid | GSE-0029-2022 | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 29221881 | tr_TR |
dc.subject.wos | Urology & nephrology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 55133912100 | tr_TR |
dc.contributor.scopusid | 55860143300 | tr_TR |
dc.contributor.scopusid | 56527372000 | tr_TR |
dc.contributor.scopusid | 56256977500 | tr_TR |
dc.contributor.scopusid | 7006244754 | tr_TR |
dc.contributor.scopusid | 6602684544 | tr_TR |
dc.contributor.scopusid | 56005080200 | tr_TR |
dc.contributor.scopusid | 35612977100 | tr_TR |
dc.subject.emtree | Aminotransferase | en_US |
dc.subject.emtree | Amlodipine | en_US |
dc.subject.emtree | Carvedilol | en_US |
dc.subject.emtree | Creatinine | en_US |
dc.subject.emtree | Eculizumab | en_US |
dc.subject.emtree | Lactate dehydrogenase | en_US |
dc.subject.emtree | Methyldopa | en_US |
dc.subject.emtree | Ramipril | en_US |
dc.subject.emtree | Eculizumab | en_US |
dc.subject.emtree | Monoclonal antibody | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Blood pressure regulation | en_US |
dc.subject.emtree | Blood smear | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Creatinine blood level | en_US |
dc.subject.emtree | Disease classification | en_US |
dc.subject.emtree | Drug withdrawal | en_US |
dc.subject.emtree | Echography | en_US |
dc.subject.emtree | Fatty liver | en_US |
dc.subject.emtree | Headache | en_US |
dc.subject.emtree | Hemolytic uremic syndrome | en_US |
dc.subject.emtree | Hepatomegaly | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human cell | en_US |
dc.subject.emtree | Human tissue | en_US |
dc.subject.emtree | Hypertension retinopathy | en_US |
dc.subject.emtree | Kidney biopsy | en_US |
dc.subject.emtree | Laboratory test | en_US |
dc.subject.emtree | Lactate dehydrogenase blood level | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Liver toxicity | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Physical examination | en_US |
dc.subject.emtree | Plasma exchange | en_US |
dc.subject.emtree | Thrombocytopenia | en_US |
dc.subject.emtree | Thrombotic thrombocytopenic purpura | en_US |
dc.subject.emtree | Treatment duration | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Hemolytic uremic syndrome | en_US |
dc.subject.emtree | Toxic hepatitis | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Oruç_vd_2018.pdf | 540.59 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License